SPR Therapeutics to Present Clinical Trial and Real-World Findings at ASPN 2022
CLEVELAND, July 14, 2022 (GLOBE NEWSWIRE) -- SPR Therapeutics announced today that two presentations highlighting SPRINTĀ® PNS in treating chronic...
CLEVELAND, July 14, 2022 (GLOBE NEWSWIRE) -- SPR Therapeutics announced today that two presentations highlighting SPRINTĀ® PNS in treating chronic...
Researchers use big data analytics to find opportunities to help alleviate drug addiction amid the U.S. opioid crisis. Since 2004,...